Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kara Kassees

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
ACS Pharmacology & Translational Science|July 18, 2024
Structure-Activity Relationship Study of Tris-Benzamides as Estrogen Receptor Coregulator Binding ModulatorsTae-Kyung Lee, Kara Kassees, Chia-Yuan Chen, et al.
Breast Cancer Research : BCR|December 28, 2019
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancersSuryavathi Viswanadhapalli, Shihong Ma, Gangadhara Reddy Sareddy, et al.
Cancers|February 10, 2024
Novel LIPA-Targeted Therapy for Treating Ovarian CancerAlexia B Collier, Suryavathi Viswanadhapalli, Rahul Gopalam, et al.
Oncogene|February 6, 2026
Therapeutic optimization of LIPA targeting to induce endoplasmic reticulum stress and cell death in ovarian cancerSuryavathi Viswanadhapalli, Tae-Kyung Lee, Scott Elmore, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
ACS Pharmacology & Translational Science|July 18, 2024
Structure-Activity Relationship Study of Tris-Benzamides as Estrogen Receptor Coregulator Binding ModulatorsTae-Kyung Lee, Kara Kassees, Chia-Yuan Chen, et al.
Breast Cancer Research : BCR|December 28, 2019
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancersSuryavathi Viswanadhapalli, Shihong Ma, Gangadhara Reddy Sareddy, et al.
Cancers|February 10, 2024
Novel LIPA-Targeted Therapy for Treating Ovarian CancerAlexia B Collier, Suryavathi Viswanadhapalli, Rahul Gopalam, et al.
Oncogene|February 6, 2026
Therapeutic optimization of LIPA targeting to induce endoplasmic reticulum stress and cell death in ovarian cancerSuryavathi Viswanadhapalli, Tae-Kyung Lee, Scott Elmore, et al.
Pageof 1